Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David H. Harpole, MD
Duke Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
73 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Toronto General Hospital
Toronto, Ontario, Canada
- University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, Alabama, United States
- John Muir/mount Diablo Cancer Center - Concord Campus
Concord, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Glendale Memorial Hospital Comprehensive Cancer Center
Glendale, California, United States
- Veterans Affairs Medical Center - Loma Linda (pettis)
Loma Linda, California, United States
- Sutter Cancer Center at Roseville Medical Center
Roseville, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- John Muir/mt. Diablo Comprehensive Cancer Center
Walnut Creek, California, United States
- Praxair Cancer Center at Danbury Hospital
Danbury, Connecticut, United States
- George Washington University Medical Center
Washington D.C., District of Columbia, United States
- Michael & Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital
Fort Lauderdale, Florida, United States
- Winship Cancer Institute of Emory University
Altanta, Georgia, United States
- Mbccop-Medical College of Georgia Cancer Center
Augusta, Georgia, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Chicago, Illinois, United States
- Cancer Institute at St. John'S Hospital
Springfield, Illinois, United States
- Regional Cancer Center at Memorial Medical Center
Springfield, Illinois, United States
- Southern Illinois University School of Medicine
Springfield, Illinois, United States
- St. Francis Hospital and Health Centers - Beech Grove Campus
Beech Grove, Indiana, United States
- Reid Hospital & Health Care Services, Incorporated
Richmond, Indiana, United States
- Jewish Hospital
Louisville, Kentucky, United States
- Greater Baltimore Medical Center Cancer Center
Baltimore, Maryland, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- William Beaumont Hospital - Royal Oak Campus
Royal Oak, Michigan, United States
- Veterans Affairs Medical Center - Minneapolis
Minneapolis, Minnesota, United States
- Mayo Clinic Cancer Center
Rochester, Minnesota, United States
- Siteman Cancer Center at Barnes-Jewish Hospital
St Louis, Missouri, United States
- Fox Chase Cancer Center at St. Francis Medical Center
Trenton, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Benedictine Hospital
Kingston, New York, United States
- South Nassau Communities Hospital
Oceanside, New York, United States
- Stony Brook University Cancer Center
Stony Brook, New York, United States
- Suny Upstate Medical University Hospital
Syracuse, New York, United States
- Duke Comprehensive Cancer Center
Durham, North Carolina, United States
- Rutherford Hospital
Rutherfordton, North Carolina, United States
- Altru Cancer Center at Altru Hospital
Grand Forks, North Dakota, United States
- Mcdowell Cancer Center at Akron General Medical Center
Akron, Ohio, United States
- Bethesda North Hospital
Cincinnati, Ohio, United States
- Cancer Treatment Center at Good Samaritan Hospital
Cincinnati, Ohio, United States
- Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2004
- Primary completion
- 30 Nov 2011
- Completion
- 30 Nov 2011
- Last update posted
- 6 Jul 2016
- Registered enrollment
- 1,000
- Registry id
- NCT00077324
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.